Form 4: Biohaven Director Gregory Bailey Acquires Stock Options
SEC Form 4
Director Gregory Bailey acquired 16,592 stock options in Biohaven Ltd. on April 30, 2024.
Summary
- On April 30, 2024, Gregory Bailey, a director of Biohaven Ltd., acquired 16,592 stock options.
- The exercise price of these options is $38.80.
- The options vest on the earlier of April 30, 2025, or the date of the 2025 Annual Meeting of Shareholders, contingent upon continuous service with the issuer.
- Following the transaction, Bailey directly owns 16,592 derivative securities.
Sentiment
Score: 5
Explanation: The document is a neutral report of a stock option grant, with no inherent positive or negative sentiment.
Industry Context
This transaction is a routine disclosure of stock option grants to a company director, common in publicly traded companies as part of executive compensation.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment as it aligns the director's interests with the company's long-term performance.
Key Dates
| Date | Description |
|---|---|
| 04/30/2024 | Date of transaction: Gregory Bailey acquired stock options. |
| 04/30/2025 | Earliest vesting date for the stock options, contingent upon continuous service. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.